Yıl: 2022 Cilt: 62 Sayı: 1 Sayfa Aralığı: 82 - 86 Metin Dili: İngilizce DOI: 10.14744/hnhj.2022.34654 İndeks Tarihi: 21-06-2022

Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy

Öz:
Introduction: This study aimed to retrospectively evaluate the perinatal outcomes of the cases followed up in our clinic for Intrahepatic cholestasis of pregnancy (ICP). Methods: In this study, the medical records of 71 patients who applied to Sakarya University Training and Research Hospital, Gynecology and Obstetrics Clinic between April 2015 and March 2021 and were diagnosed with ICP were analyzed retrospectively. Results: The mean age of the patients was 28.9±4.8 years. At the time of diagnosis, the mean week of gestation was 31.9±2.4 weeks, and the mean week of gestation at birth was 36.7±1.5 weeks. It was determined that 20 (28.2%) of the patients had preterm birth before 37 weeks of gestation. The gestational week at the time of diagnosis was found to be statistically significantly lower in patients who had preterm birth (30.5±1.7) compared to those who did not (32±2.5) who did not have preterm birth (p:0.025). When the correlation analysis was performed, a statistically significant negative correlation was found between the gestational week at the time of diagnosis and preterm birth (p=0.024, r=−0.268). Discussion and Conclusion: Although ICP is a benign condition for the mother, it can cause significant complications in the fetus. Therefore, early diagnosis and active management are essential in reducing adverse complications related to ICP.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Dixon PH, Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy. Clin Res Hepatol Gastroenterol 2016;40:141–53.
  • 2. Shao Y, Chen J, Zheng J, Liu CR. Effect of histone deacetylase HDAC3 on cytokines IL-18, IL-12 and TNF-α in patients with intrahepatic cholestasis of pregnancy. Cell Physiol Biochem 2017;42:1294–302.
  • 3. Clinical updates in women's health care summary: Liver disease: Reproductive considerations. Obstet Gynecol 2017;129:236.
  • 4. Wikström Shemer E, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: A 12-year populationbased cohort study. BJOG 2013;120:717–23.
  • 5. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009;15:2049–66.
  • 6. Joshi D, James A, Quaglia A, Westbrook RH, Heneghan MA. Liver disease in pregnancy. Lancet 2010;375:594–605.
  • 7. Ovadia C, Seed PT, Sklavounos A, Geenes V, Di Ilio C, Chambers J, et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: Results of aggregate and individual patient data meta-analyses. Lancet 2019;393:899–909.
  • 8. Labbe C, Delesalle C, Creveuil C, Dreyfus M. Cholestases intrahepatiques gravidiques (CIG) précoces et tardives : étude des complications materno-foetales [Early and later intrahepatic cholestasis of pregnancy (ICP): Study of adverse pregnancy outcomes]. Gynecol Obstet Fertil Senol 2018;46:388–94. [Article in French]
  • 9. Yang J, Chen C, Liu M, Zhang S. Women successfully treated for severe intrahepatic cholestasis of pregnancy do not have increased risks for adverse perinatal outcomes. Medicine (Baltimore) 2019;98:e16214.
  • 10. Geenes VL, Lim YH, Bowman N, Tailor H, Dixon PH, Chambers J, et al. A placental phenotype for intrahepatic cholestasis of pregnancy. Placenta 2011;32:1026–32.
  • 11. Ibrahim E, Diakonov I, Arunthavarajah D, Swift T, Goodwin M, McIlvride S, et al. Bile acids and their respective conjugates elicit different responses in neonatal cardiomyocytes: Role of Gi protein, muscarinic receptors and TGR5. Sci Rep 2018;8:7110.
  • 12. Güven D, Altunkaynak BZ, Altun G, Alkan I, Kocak I. Histomorphometric changes in the placenta and umbilical cord during complications of pregnancy. Biotech Histochem 2018;93:198– 210.
  • 13. Cui D, Zhong Y, Zhang L, Du H. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis. J Obstet Gynaecol Res 2017;43:1411–20.
  • 14. South australia maternal & neonatal community of practice. Obstetric cholestasis. Available at: https://www.sahealth. sa.gov.au/wps/wcm/connect/f91fbf004ee530b2a5ebadd150ce4f37/ obstetric+cholestasis_27042016. pdf?MOD=AJPERES. Accessed Apr, 2016.
  • 15. Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines. Eur J Obstet Gynecol Reprod Biol 2018;231:180–7.
  • 16. Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 2004;40:467–74.
  • 17. Kondrackiene J, Beuers U, Zalinkevicius R, Tauschel HD, Gintautas V, Kupcinskas L. Predictors of premature delivery in patients with intrahepatic cholestasis of pregnancy. World J Gastroenterol 2007;13:6226–30.
  • 18. Pata O, Vardarelı E, Ozcan A, Serteser M, Unsal I, Saruç M, et al. Intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with bile acids. Turk J Gastroenterol 2011;22:602–5.
  • 19. Germain AM, Kato S, Carvajal JA, Valenzuela GJ, Valdes GL, Glasinovic JC. Bile acids increase response and expression of human myometrial oxytocin receptor. Am J Obstet Gynecol 2003;189:577–82.
  • 20. Zhang Y, Hu L, Cui Y, Qi Z, Huang X, Cai L, et al. Roles of PPARγ/ NF-κB signaling pathway in the pathogenesis of intrahepatic cholestasis of pregnancy. PLoS One 2014;9:e87343.
  • 21. Sargın Oruç A, Seçkin B, Özcan N, Özyer S, Uzunlar Ö, Danışman N. Role of postprandial bile acids in prediction of perinatal outcome in intrahepatic cholestasis of pregnancy. J Obstet Gynaecol Res 2014;40:1883–9.
  • 22. Madazli R, Yuksel MA, Oncul M, Tuten A, Guralp O, Aydin B. Pregnancy outcomes and prognostic factors in patients with intrahepatic cholestasis of pregnancy. J Obstet Gynaecol 2015;35:358–61.
  • 23. Berg B, Helm G, Petersohn L, Tryding N. Cholestasis of pregnancy. Clinical and laboratory studies. Acta Obstet Gynecol Scand 1986;65:107–13.
  • 24. Jin J, Pan SL, Huang LP, Yu YH, Zhong M, Zhang GW. Risk factors for adverse fetal outcomes among women with earlyversus late-onset intrahepatic cholestasis of pregnancy. Int J Gynaecol Obstet 2015;128:236–40.
  • 25. Yule CS, Holcomb DS, Kraus AC, Brown CEL, McIntire DD, Nelson DB. Cholestasis: A prospective study of perinatal outcomes and time to symptom improvement. Am J Perinatol 2021;38:414–20.
  • 26. Behboudi-Gandevani S, Amiri M, Bidhendi Yarandi R, Ramezani Tehrani F. The impact of diagnostic criteria for gestational diabetes on its prevalence: A systematic review and meta-analysis. Diabetol Metab Syndr 2019;11:11.
  • 27. Ives CW, Sinkey R, Rajapreyar I, Tita ATN, Oparil S. Preeclampsia- pathophysiology and clinical presentations: JACC State-ofthe- Art review. J Am Coll Cardiol 2020;76:1690–702.
  • 28. Di Mascio D, Quist-Nelson J, Riegel M, George B, Saccone G, Brun R, et al. Perinatal death by bile acid levels in intrahepatic cholestasis of pregnancy: A systematic review. J Matern Fetal Neonatal Med 2021;34:3614–22.
APA gök k, Özgül A, YILMAZ E, Gök N, bostanci m, ozden s (2022). Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. , 82 - 86. 10.14744/hnhj.2022.34654
Chicago gök koray,Özgül Asude,YILMAZ Erdal,Gök Nazife reyyan,bostanci mehmet suhha,ozden selcuk Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. (2022): 82 - 86. 10.14744/hnhj.2022.34654
MLA gök koray,Özgül Asude,YILMAZ Erdal,Gök Nazife reyyan,bostanci mehmet suhha,ozden selcuk Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. , 2022, ss.82 - 86. 10.14744/hnhj.2022.34654
AMA gök k,Özgül A,YILMAZ E,Gök N,bostanci m,ozden s Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. . 2022; 82 - 86. 10.14744/hnhj.2022.34654
Vancouver gök k,Özgül A,YILMAZ E,Gök N,bostanci m,ozden s Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. . 2022; 82 - 86. 10.14744/hnhj.2022.34654
IEEE gök k,Özgül A,YILMAZ E,Gök N,bostanci m,ozden s "Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy." , ss.82 - 86, 2022. 10.14744/hnhj.2022.34654
ISNAD gök, koray vd. "Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy". (2022), 82-86. https://doi.org/10.14744/hnhj.2022.34654
APA gök k, Özgül A, YILMAZ E, Gök N, bostanci m, ozden s (2022). Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. Haydarpaşa Numune Medical Journal, 62(1), 82 - 86. 10.14744/hnhj.2022.34654
Chicago gök koray,Özgül Asude,YILMAZ Erdal,Gök Nazife reyyan,bostanci mehmet suhha,ozden selcuk Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. Haydarpaşa Numune Medical Journal 62, no.1 (2022): 82 - 86. 10.14744/hnhj.2022.34654
MLA gök koray,Özgül Asude,YILMAZ Erdal,Gök Nazife reyyan,bostanci mehmet suhha,ozden selcuk Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. Haydarpaşa Numune Medical Journal, vol.62, no.1, 2022, ss.82 - 86. 10.14744/hnhj.2022.34654
AMA gök k,Özgül A,YILMAZ E,Gök N,bostanci m,ozden s Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. Haydarpaşa Numune Medical Journal. 2022; 62(1): 82 - 86. 10.14744/hnhj.2022.34654
Vancouver gök k,Özgül A,YILMAZ E,Gök N,bostanci m,ozden s Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy. Haydarpaşa Numune Medical Journal. 2022; 62(1): 82 - 86. 10.14744/hnhj.2022.34654
IEEE gök k,Özgül A,YILMAZ E,Gök N,bostanci m,ozden s "Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy." Haydarpaşa Numune Medical Journal, 62, ss.82 - 86, 2022. 10.14744/hnhj.2022.34654
ISNAD gök, koray vd. "Evaluation of Perinatal Outcomes in Intrahepatic Cholestasis of Pregnancy". Haydarpaşa Numune Medical Journal 62/1 (2022), 82-86. https://doi.org/10.14744/hnhj.2022.34654